USP5 and neuroblastoma: Combination drug treatment with SAHA and SE486-11 reduced MYCN, USP5 and PCNA (proliferation marker) protein levels in neuroblastoma-bearing MYCN;GFP zebrafish compared to DMSO treated controls (Fig. 2d; Fig. S2f).